In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers

Journal of Controlled Release

Volumn 44, Issue 1, 1997, Pages 65-76

  Dunn, Susan E ^a   Coombes, Allan G A ^a   Garnett, Martin C ^a   Davis, Stanley S ^a   Davies, Martyn C ^a   Illum, Lisbeth ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Nanosphere; Poloxamer; Poloxamine; Poly(ethylene glycol); Poly(lactide co glycolide)

Indexed keywords

COPOLYMER; DRUG CARRIER; MACROGOL; NANOPARTICLE; POLOXAMER; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

EID: 0031016078     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01504-0     Document Type: Article

References (36)

1. G. Poste, Liposome targeting in vivo. Problems and opportunities. Biol. Cell 47 (1983) 1-38.
2. L. Illum and S.S. Davis, The organ uptake of intravenously administered colloidal particles can be altered using nonionic surfactant (poloxamine 338). FEBS Lett. 167 (1984) 79-82.
3. J. Senior, C. Delgado, D. Fisher, C. Tilcock and G. Gregoriadis, Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1062 (1991) 77-82.
4. R.H. Muller, K.H. Wallis, S.D. Troster and J. Kreuter, In vitro characterisation of poly(methyl methacrylate) nanoparticles and correlation to their in vivo fate. J. Control. Release 20 (1992) 237-246.
5. L. Illum, L.O. Jacobsen, R.H. Muller, E. Mak and S.S. Davis, Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8 (1987) 113-117.
6. L. Illum, S.S. Davis, R.H. Muller, E. Mak and P. West, The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer: poloxamine 908. Life Sci. 40 (1987) 367-374.
7. C.J.H. Porter, S.M. Moghimi, L. Illum and S.S. Davis, The polyoxyethylene/polyoxypropylene block copolymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Letts. 305 (1992) 62-66.
8. I.S. Muir, S.M. Moghimi, L. Illum, S.S. Davis and M.C. Davies, The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells - in vitro and in vivo studies. Biochem. Soc. Trans. 19 (1991) 329S.
9. I.S. Muir, PhD Thesis, University of Nottingham, 1992.
10. J.B. Kayes and D.A. Rawlins, Adsorption characteristics of certain polyoxyethylene-polyoxypropylene block co-polymers on polystyrene latex. Colloid Polym. Sci. 257 (1979) 622-629.
11. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis and V. Kolb-bachofen, Coating particles with a block co-polymer (poloxamine 908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta 1179 (1993) 157-165.
12. J.S. Tan, D.E. Butterfield, C.L. Voycheck, K.D. Caldwell and J.T. Li, Surface modification of nanoparticles by PEO/PP0 block copolymers to minimize interactions with blood components and prolong blood circulation in rats. Biomaterials 14 (1993) 823-833.
13. S.E. Dunn, A. Brindley, S.S. Davis, M.C. Davies and L. Illum, Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model systems for site specific delivery. Part 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm. Res. 11 (1994) 1016-1022.
14. S. Stolnik, S.E. Dunn, M.C. Garnett, M.C. Davies, A.G.A. Coombes, D.C. Taylor, M.P. Irving, S.C. Purkiss, Th.F. Tadros, S.S. Davis and L. Illum, Surface modification of poly(lactide-co-glycolide) nanospheres by novel biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm. Res. 11 (1994) 1800-1808.
15. 14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13 (1992) 1093-1102.
16. M. Kanke, E. Morlier, R. Geissler, D. Powell, A. Kaplan and P.P. Deluca, Interaction of microspheres with blood constituents. II. Uptake of biodegradable particles by macrophages. J. Parent. Sci. Tech. 40 (1986) 114-118.
17. R.H. Muller and K.H. Wallis, Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908. Int. J. Pharm. 89 (1993) 25-31.
18. R.H. Muller, S. Heinemann, T. Blunk and S. Rudt, PCS and Zeta potential characterisation of model drug carriers -essential information for the interpretation of in vitro and in vivo data. In: S.E. Harding, D.B. Sattelle and V.A. Bloomfield (Eds.), Laser Light Scattering in Biochemistry, R.S.C. Cambridge, UK, 1992, pp. 425-440.
19. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin and R. Langer, Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603.
20. P.D. Scholes, A.G.A. Coombes, L. Illum, S.S. Davis and M.C. Davies, A comparison of production methods to produce biodegradable microspheres with similar surface properties to model particulate systems which avoid the RES. (in preparation).
21. H. Fessi, F. Puisieux and J.P. Devissaguet. Procede de preparation de systemes colloidaux dispersibles d'une substance sous forme de nanocapsules. Eur. Pat. Appl. 0274961A1, July 20th, 1988.
22. P.N. Pusey, D.E. Koppel, D.W. Schaeffer, R.D. Camerini-Otero and S.H. Koenig, Intensity fluctuation spectroscopy of laser light scattered by solutions of spherical viruses: R17, Qβ, BSV, PM2 and T7. 1. Light Scattering Technique, Biochemistry 13 (1974) 952-960.
23. P.D. Scholes, M.C. Davies, L. Illum and S.S. Davis, Radio-labelling of biodegradable microspheres for site-specific drug delivery. Proc. Int. Symp. Control. Release Bioact. Mater. 19 (1992) 154-155.
24. Y. Huh, W. Donaldson and F.J. Johnson, A radiation induced bonding of iodine at the surface of uniform polystyrene particles. Radiat. Res. 60 (1974) 42-53.
25. S.M. Moghimi and H.M. Patel, Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Letts. 233 (1988) 143-147.
26. W.A. Ritschel, In vivo animal models for bioavailability assessment. S.T.P. Pharma 3 (1987) 125-141.
27. T.I. Armstrong, M.C. Davies and L. Illum, Human serum albumin as a probe for protein adsorption. Relevance to biodistribution, (submitted for publication).
28. B. Kroberg, P. Stenius and G. Igeborn, The effect of surface polarity on the adsorption of nonionic surfactants. II. Adsorption on poly(methyl methacrylate) latex. J. Colloid Interface Sci. 102 (1984) 418-423.
29. T. Cosgrove, T.G. Heath, K. Ryan and B. Van Lent, The conformation of adsorbed poly(ethylene oxide) at the polystyrene/water interface. Polym. Commun. 28 (1987) 64-65.
30. N. Waltrous-Peltier, J. Uhl, V. Steel, L. Brophy and E. Merisko-Liversidge, Direct suppression of phagocytosis by amphipathic polymeric surfactants. Pharm. Res. 9 (1992) 1177-1183.
31. H-J. Krause, A. Schwarz and P. Rohdewald, Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs. Int. J. Pharm. 27 (1985) 145-155.
32. G. Splenlehauer, T. Verrecchia, Y. Archimbaud, D. Bazile, M. Marland and M. Veillard, Stealth PLA-PEG nanoparticles: biopharmaceutical and biochemical aspects. 3rd Eur. Symp. Control. Drug Del. (1994).
33. S.J. Douglas, S.S. Davis and L. Illum, Biodistribution of poly(butyl-2-cyanoacrylate) nanoparticles in rabbits. Int. J. Pharm. 34 (1986) 145-152.
34. S.M. Moghimi, C.J.H. Porter, I.S. Muir, L. Illum and S.S. Davis, The effect of poloxamer 407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres. Int. J. Pharm. 68 (1991) 121-126.
35. S.D. Troster, U. Muller and J. Kreuter, Modification of the body distribution of poly (methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm. 61 (1990) 85-100.
36. 14C-poly(methyl methacrylate) nanoparticles. J. Microencapsul. 9 (1992) 19-28.